发明名称 |
GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
摘要 |
The invention is a method and composition for the prevention and treatment of type I and type II diabetes in a subject. The composition comprises an IgG-Fc fusion protein where the fusion protein comprises GLP-1, mutant GLP-1, or exendin-4. |
申请公布号 |
EP1920061(A4) |
申请公布日期 |
2009.05.13 |
申请号 |
EP20060761187 |
申请日期 |
2006.07.27 |
申请人 |
WANG, QINGHUA |
发明人 |
PRUD'HOMME, GERALD, J.;KUMAR, MOHAN |
分类号 |
C12N15/62;A61K38/26;A61K47/48;C07K14/605;C07K16/00;C07K19/00;C12N1/21;C12N5/10;C12N15/13;C12N15/16;C12N15/63;C12P21/02 |
主分类号 |
C12N15/62 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|